Chester County News and Community Website
Teleflex Incorporated (NYSE: TFX), headquartered in Wayne, PA, is a global provider of medical technologies designed to improve the health and quality of people’s lives, with solutions in the fields of vascular and interventional access, surgical, anesthesia, cardiac care, urology, emergency medicine and respiratory care.
WAYNE, PA — Teleflex Incorporated (NYSE: TFX) will pay a quarterly cash dividend of $0.34 per common share on Sept. 30, 2026, following approval by the medical technology company’s board …
Teleflex Sets 34-Cent Quarterly Dividend for September Read More WAYNE, PA — Teleflex Incorporated (NYSE: TFX) lowered its 2026 revenue outlook after integration of the acquired Biotronik Vascular Intervention business took longer than expected, even as second-quarter continuing-operations revenue …
Teleflex Cuts Revenue Outlook as Biotronik Integration Slows Read More WAYNE, PA — Teleflex Incorporated (NYSE: TFX) completed the $1.5 billion cash sale of its OEM business to Montagu and Kohlberg, giving the medical technology company an estimated $1.25 billion …
Teleflex Closes $1.5 Billion OEM Sale, Targets Debt and Buybacks Read More WAYNE, PA — Teleflex Inc. (NYSE: TFX) has secured U.S. Food and Drug Administration approval for the first licensed freeze-dried plasma product in the country, potentially expanding access to plasma …
Teleflex Wins FDA Approval for Shelf-Stable Plasma Product Read More WAYNE, PA — Teleflex Incorporated (NYSE: TFX) will discuss its second-quarter financial results and provide an operational update during a conference call at 8 a.m. ET on Aug. 6, giving …
Teleflex Sets Aug. 6 Call for Second-Quarter Update Read More WAYNE, PA — Teleflex Incorporated (NYSE: TFX) secured a national group purchasing agreement with Premier Inc. that gives participating health systems access to pre-negotiated pricing on central venous, arterial and …
Teleflex Wins Premier Vascular Access Supply Agreement Read More WAYNE, PA — Teleflex Inc. (NYSE: TFX) has released its 2025 Global Impact Report, detailing environmental, governance and social responsibility initiatives that investors and other stakeholders increasingly use to evaluate …
Teleflex Details ESG Progress in 2025 Global Impact Report Read More WAYNE, PA — Teleflex Inc. (NYSE: TFX) has begun enrolling patients in a global pivotal study of its Freesolve resorbable magnesium scaffold, advancing the company’s effort to bring a temporary …
Teleflex Launches Pivotal Trial for Resorbable Heart Scaffold Read More WAYNE, PA — Teleflex Incorporated (NYSE: TFX) reported four-year follow-up results from a first-in-human clinical study of its Freesolve resorbable magnesium coronary scaffold, providing long-term safety data as the company …
Teleflex Reports Four-Year Data for Resorbable Heart Scaffold Read More WAYNE, PA — Teleflex (NYSE: TFX) reported new clinical data supporting two of its urology products as the company prepares to divest its Interventional Urology business later this year, a …
Teleflex Reports New Data Ahead of Urology Unit Sale Read More